US Stock MarketDetailed Quotes

OASMY Oasmia Pharmaceutical AB ADR

Watchlist

0.020000
0.0000000.00%

15min DelayClose Apr 12 16:00 ET

3.59MMarket Cap-303P/E (TTM)

Oasmia Pharmaceutical AB ADR Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oasmia Pharmaceutical AB ADR Earnings Date

Currency: SEK

Period

Q4 FY2023 Earnings

Feb 23, 2024

Revenue(YoY)

0.00

0.00%

EPS(YoY)

-0.36

+72.73%

Analyst Rating

No Data

Oasmia Pharmaceutical AB ADR Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: SEK

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Feb 24, 2022	2021/Q4	9.639M / 200.000K	--
Nov 18, 2021	2021/Q3	11.920M / 200.000K	--
Aug 19, 2021	2021/Q2	4.596M / 200.000K	--

DatePeriodRevenue/EstimateEarnings Call

Feb 24, 20222021/Q49.639M / 200.000K--

Nov 18, 20212021/Q311.920M / 200.000K--

Aug 19, 20212021/Q24.596M / 200.000K--

Oasmia Pharmaceutical AB ADR Earnings Reports

Oasmia Pharmaceutical AB ADR | 20-F: FY2018 Annual Report

Sep 14, 2018 16:07 ET

Oasmia Pharmaceutical AB ADR | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Oct 31, 2017 16:05 ET

Oasmia Pharmaceutical AB ADR: FY2017 Annual Report

20-F | Oasmia Pharmaceutical AB (0001607245) (Filer)

Aug 24, 2017 16:05 ET

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall